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Depression and Posttraumatic Stress Disorder
Among Women with Vulvodynia:
Evidence from the Population-Based
Woman to Woman Health Study
Lisbeth Iglesias-Rios, MA, MPH,1 Sioba´n D. Harlow, PhD,1 and Barbara D. Reed, MD2
Background: Psychological disorders may affect the pain experience of women with vulvodynia, but evidence
remains limited. The present study aimed to describe the magnitude of the association of depression and
posttraumautic stress disorder (PTSD) with the presence of vulvodynia in a nonclinical population from
southeastern Michigan.
Methods: Baseline data from 1,795 women participating in the Woman to Woman Health Study, a multiethnic
population-based study, was used for this analysis. Validated screening questionnaires were conducted to assess
vulvodynia, depression, and PTSD. Modified Poisson regression models with a robust variance estimation were
used to estimate prevalence ratios (PR) and their 95% confidence intervals (CI) for the association between
vulvodynia status and two mental health conditions, depression and PTSD.
Results: In the adjusted models, women who screened positive for depression had a 53% higher prevalence of
having vulvodynia (PR= 1.53; 95% CI: 1.12, 2.10) compared with women who screened negative for de-
pression. Women who screened positive for PTSD had more than a two-fold increase in the prevalence of
having vulvodynia (PR= 2.37; 95% CI: 1.07, 5.25) compared with women who screened negative for PTSD.
Conclusions: The increased prevalence of vulvodynia among those screening positive for depression or PTSD
suggests that these disorders may contribute to the likelihood of reporting vulvodynia. Alternatively, vulvodynia,
depression, and PTSD may have a common pathophysiological and risk profile. Prospective studies are needed to
improve our understanding of the temporal relation between mental health conditions and vulvar pain.
Introduction
Vulvodynia, a chronic pain syndrome associatedwith burning, stinging, irritation, or sharp vulvar pain,
has a prevalence in the United States of 7%–10%.1,2 Pain
presentation varies and may be described as spontaneous,
provoked by stimulation (i.e., intercourse or tampon use), or
both.1,3 While some studies have documented that women
with vulvodynia report a poor quality of life4,5 and suffer
from psychological distress manifested as anxiety and de-
pression,6–10 evidence of an association between vulvodynia
and mental health outcomes remains limited.
Pain is a complex perceptual phenomenon that is modu-
lated by sensory, psychological, and social influences.11 Data
suggest symptoms of physiological arousal (e.g., racing
heart, sweating palms, dizziness) and experiencing negative
thoughts and emotions—common symptoms in anxiety and
depression disorders—may be associated with the mainte-
nance or exacerbation of symptoms of vulvar pain.7,12–14
Likewise, one or more aspects of the pain experience (e.g.,
physiological arousal, pain-related catastrophizing, avoid-
ance of physical exertion) may exacerbate clinically signifi-
cant symptoms of anxiety and depression.15 As such, it is
plausible that the pathway between vulvodynia and psycho-
logical disorders such as anxiety, posttraumatic stress disor-
der (PTSD), and depression is bidirectional. A cycle of
symptoms associated with anxiety, depression, PTSD, and
pain may perpetuate distress and functional disability.11,15
Alternatively, pain and psychological disorders may share an
etiologic pathway or common susceptibility.15
Women with vulvodynia may have greater brain activation
in regions of the central nervous system that are associated
with pain and sensory processing.16 In particular, activation
in the insula, a sensory integration region involved in pain
and sensory processing, has been found to be associated with
anxiety disorders such as PTSD,17 as well as vulvar pain.16–18
Serotonin and norepinephrine are neurotransmitters that
have been implicated in the underlying pathophysiology of
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chronic pain and are known to be associated with anxiety and
depressive disorders.19–21 Recognizing that anxiety and de-
pression cause a significant burden of morbidity and dis-
ability22,23 and that the nature of the interrelationship
between vulvar pain and mental health remains unclear, the
aim of this paper was to describe the magnitude of the as-
sociation between PTSD and/or depression and the presence
of vulvodynia among a racially/ethnically diverse popula-
tion-based sample of women.
Materials and Methods
Data source and participants
This cross-sectional study was conducted using data from
the Woman to Woman Health Study, which was approved by
the University of Michigan Medical Institutional Review
Board. As previously described,24 the Woman to Woman
Health Study (2008–2013) was designed to determine the
prevalence of vulvodynia among a multiethnic population-
based sample of women from four counties in southeastern
Michigan. Women aged 18 and older were recruited using
random digit dialing by the Survey Research Center in the
Institute of Social Research at the University of Michigan.
Participants were asked to complete an online or written
survey within 2 weeks of enrollment, and follow-up surveys
repeated every 6 months for 3 years. Informed consent was
obtained at the time of the telephone recruitment call and
again with each subsequent survey.
This analysis included data from the baseline survey
(n = 2,277). The questionnaire included previously validated
screening questionnaires to assess vulvodynia,25 depres-
sion,26,27 and PTSD,28 as well as information on socio-
demographic characteristics and reproductive health history.25
A total of 123 respondents were excluded due to missing
screening data for vulvodynia status (n = 84) or depression
(n = 39). We restricted the analysis to women aged 18–65
years old, as data in women older than 65 years was sparse,
yielding a final sample of 1,795 participants.
Measures
We used a previously validated screening instrument of
self-reported genital symptoms of vulvodynia with a sensi-
tivity of 81.8% and specificity of 96.6% when compared with
clinical examination.25 Women were classified into one of
three vulvodynia status categories: vulvodynia case, short-
term or past vulvar symptoms not meeting criteria for current
vulvodynia, and women without vulvar symptoms. A woman
screened positive for vulvodynia if she reported pain at the
introitus (opening of the vagina), had vulvar symptoms that
were provoked (e.g., sexual intercourse or tampon use) or
unprovoked, and whose symptoms had lasted a minimum of 3
months. Women with similar vulvar pain symptoms or dys-
pareunia that were not current or had not been present for at
least 3 months were classified as having short-term or past
vulvar symptoms. The no vulvar symptom group was defined
as women with no history of vulvar pain lasting 3 months or
longer, and no current vulvar pain or pain with intercourse.
The Patient Health Questionnaire depression scale (PHQ-
8), a standardized and validated instrument, was used to
screen for current depression.26,27 This screening scale asks
about eight of the nine criteria on which the Diagnostic and
Statistical Manual, Fourth Edition, (DSM-IV) diagnosis of
depressive disorders is based.29 Each item asks patients to
indicate the frequency with which they experienced the
symptom during the 2 weeks before the interview, scored on a
four-point Likert scale from ‘‘not at all’’ to ‘‘every day or
nearly every day.’’ A PHQ-8 score of ‡ 10 has 88% sensi-
tivity and 88% specificity for major depression30 and typi-
cally represents clinically significant depression.31,32
PTSD was defined as positive, suggestive, or negative as
assessed by the primary care PTSD screen.28 This instrument
consists of four items that assess the presence of the main
PTSD symptom clusters (intrusive experiencing, avoidance
behaviors, hypervigilance, and emotional numbing). Parti-
cipants receive one point for each item endorsed. A score of
three or more has demonstrated sensitivity and specificity for
identifying individuals diagnosed with positive PTSD in
primary care (78% and 87%, respectively) or having clini-
cally significant PTSD symptoms,28,33 A score of two is
considered suggestive of PTSD.
The following covariates included in this analysis were the-
ory driven.7,12,34–36 and based on our prior analyses of the
prevalence and incidence of vulvodynia:1,24 age in years, self-
reported race/ethnicity (white,AfricanAmerican,Hispanic, and
other), marital status or living with a partner (yes/no), sexual
intercourse within the past 6 months (yes/no), and education
(high school or less, some college, and graduated college).
Statistical analysis
We calculated frequencies and conducted bivariate analyses
with cross tabulations using chi-squares and t-tests to assess
associations between depression, PTSD, and covariates with
vulvodynia status. Unadjusted and adjusted modified Poisson
regression models with a robust variance estimation were used
to estimate prevalence ratios (PRs) and their 95% confidence
intervals (CI)37 for the association between vulvodynia status
and the two mental health conditions (depression and PTSD).
This statistical approachwas chosen because it is considered to
be a direct and less biased approach to estimating the PRs. We
fit separate binary modified Poisson regression models,38,39
one model for women with vulvodynia and another one for
women with short-term or past vulvar symptoms defining
women without vulvodynia as the referent group. Adjusted
models included both depression and PTSD as well as the
covariates specified above. We also evaluated the potential
interaction between depression and PTSD. All analyses were
performed using SAS version 9.2 (SAS Institute, Inc., Cary,
NC) with PROC GENMOD and the robust variance estimator
provided by the REPEATED statement that uses themethod of
generalized estimating equations to estimate the model and
give a proper estimate of the standard error of the PRs.
Results
A total of 221 (12.5%) of the 1,795 women screened posi-
tive for vulvodynia, and an additional 609 (33.9%) reported
short-term or past vulvar symptoms. Table 1 presents the
characteristics of the study population stratified by vulvodynia
status. The mean age of women in the study was 44.6 years
(standard deviation, SD= 12.74), most were white (73.6%),
married (68.0%), and had had sexual intercourse in the last 6
months (73.3%). Slightly more than half of the population had
graduated from college (51.9%) and had household income
558 IGLESIAS-RIOS ET AL.
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greater than $60,000 per year (57.0%). The mean age was 45.0
(standard deviation [SD]= 12.37) for women with vulvodynia,
43.0 (SD= 12.53) for those with short-term or past vulvar
symptoms, and 46.0 (SD= 12.8) for those without vulvodynia.
Women without vulvodynia were more likely to be African
American and less likely to graduate from college or to have
incomes greater than $60,000 a year, to be married or report
having had sexual intercourse in the past 6 months.
A total of 13.8% of the women screened positive for de-
pression, and 13.0% screened positive for PTSD.Women with
vulvodynia were more likely to screen positive for depression
(20.8%) than women with short-term or past vulvar symptoms
(12.5%) and women without vulvodynia (13.1%). Women
with current vulvodynia weremost likely to screen positive for
PTSD (20.0%) than women with short-term or past vulvar
symptoms (15.3%), and women without vulvodynia (9.5%).
Among women with vulvodynia, 12.0% of women screened
positive for both depression and PTSD (data not shown).
Results from the crude and adjusted modified Poisson re-
gression models are presented in Table 2. After adjustment for
race/ethnicity,marital status, and sexual intercourse in the past 6
months, prevalence ratios comparing women with current vul-
vodynia to women without vulvodynia remained significantly
elevated for both PTSD and depression. In the adjusted models,
women who screened positive for depression had a statistically
significant higher prevalence of current vulvodynia (PR= 1.53;
95% CI: 1.12, 2.10) compared with women who screened
negative for depression. Women who screened positive for
PTSD had a statistically significant doubling in the prevalence
of current vulvodynia (PR= 2.37; 95%CI: 1.07, 5.25) compared
to women who screened negative for PTSD. The prevalence of
current vulvodynia was also significantly higher (PR=1.54;
95% CI: 1.04, 2.29) among women with suggestive PTSD than
among women who screened negative for PTSD. The preva-
lence of having short-term or past vulvar symptoms were also
significantly elevated among women who screened positive for
PTSD (PR= 1.62; 95% CI: 1.07, 2.44) but not among women
who screened positive for depression (PR= 0.85; 95% CI: 0.69,
1.06) compared to those who screened negative for these con-
ditions respectively. When we included an interaction term for
depression and PTSD in each model, the interaction was not
statistically significant (data not shown).
Discussion
Our results indicate a strong association between screening
positive for PTSD or depression and screening positive for
vulvodynia in this multiethnic population-based study.While it
is well documented that individuals with depression and/or
PTSD have a significant increase in various pain condi-
tions.11,15,18,40,41 little research has addressed this question
amongwomenwith vulvodynia.7,12We found that womenwho
Table 1. Sociodemographic Characteristics of 1,795 Women Aged 18–65 Years by Vulvodynia Status:
The Woman to Woman Health Study
Total
Women
with
vulvodynia
Women with
short-term or past
vulvar symptoms
Women
without
vulvodynia
Characteristics n (%) n (%) n (%) n (%) p
Total 1,795 221 (12.5%) 609 (33.9%) 965 (53.8%)
Race and Ethnicity
White 1,321 (73.6) 179 (81.0) 464 (76.2) 678 (70.3) 0.0001
African-American 325 (18.1) 21 (9.5) 94 (15.4) 210 (21.8)
Hispanic 50 (2.8) 8 (3.6) 22 (3.6) 20 (2.1)
Other 99 (5.5) 13 (5.9) 29 (4.8) 57 (6.0)
Education
High school or less 426 (23.8) 45 (20.4) 132 (21.7) 249 (25.8) 0.05
Some college 437 (24.4) 50 (22.6) 141 (23.2) 246 (25.5)
Graduated college 931 (51.9) 126 (57.0) 336 (55.2) 469 (48.7)
Incomea
> 60,000 892 (57.0) 118 (60.2) 336 (61.0) 438 (53.6) 0.02
£ 60,000 672 (43.0) 78 (39.8) 215 (39.0) 379 (46.4)
Married
Yes 1211 (68.0) 174 (79.1) 426 (70.5) 611 (63.9) < 0.0001
No 570 (32.0) 46 (20.9) 178 (29.5) 346 (36.2)
Had sexual intercourse in the past 6 months
Yes 1287 (73.3) 173 (79.4) 494 (82.2) 620 (66.1) < 0.0001
No 470 (26.8) 45 (20.6) 107 (17.8) 318 (33.9)
Screened positive for depression
Yes 248 (13.8) 46 (20.8) 76 (12.5) 126 (13.1) 0.005
No 1,547 (86.2) 175 (79.2) 533 (87.5) 839 (86.9)
Screened positive for PTSD
Yes 229 (12.8) 44 (19.9) 93 (15.3) 92 (9.5) < 0.0001
Suggestive 156 (8.7) 25 (11.3) 64 (10.5) 67 (6.9)
No 1,410 (78.6) 152 (68.8) 452 (74.2) 806 (83.5)
aIncome data missing in 231 cases.
PTSD, posttraumatic stress disorder.
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screened positive for PTSD had more than a two-fold increase
in the prevalence of screening positive for vulvodynia, while
women who screened positive for depression or suggestive
PTSD had a 50% increase in the prevalence of having this
gynecological pain condition.
A previous community-based case-control study reported
antecedent anxiety and depressive disorders were associated
with vulvodynia using DSM-IV criteria and a structured
clinical interview (SCID).7 These authors also reported that
vulvodynia was associated with subsequent risk of anxiety and
depression, suggesting a possible bidirectional relationship
and/or a common risk profile. However, establishing definitive
dates of onset of vulvodynia is difficult and subject to recall
bias, a limitation of the case-control approach. A clinical study
of vulvodynia patients reported that anxiety and depression
scores, based on the Symptom Checklist 90 Revised, were
modestly correlated with pain severity.34 Our findings are
consistent with these previous findings.7,12,34 Ours is the first
paper to consider PTSD as a potential risk factor and suggests
that depression and PTSD are independently associated with
the prevalence of having vulvodynia. These findings would be
consistent with the hypothesis that depression and/or PTSD
may contribute to the risk of vulvodynia but would also be
consistent with these disorders having a common pathophys-
iology and risk profile. Further research is needed to clarify the
temporal relationship between these conditions.
Relatively little is known about the mechanisms underly-
ing the relationship between anxiety disorders and pain
conditions, but it is well recognized that PTSD and chronic
pain share a number of symptoms (e.g., anxiety and hyper-
arousal, avoidance behavior, emotional lability, and somatic
focus).11 Similarly, both PTSD and chronic pain are multi-
dimensional constructs comprising symptom clusters in the
cognitive, behavioral, and physiological domains.11
Clinical and experimental evidence suggest that the ex-
perience of emotional trauma in and of itself may relate to
significant differences in the functioning of emotional pro-
cessing circuits. PTSD and depression can be triggered by
stressful life events42–44 that are characterized by activation
in the physiological and neuroendocrine systems.45–47 In-
creased anterior insula activation is commonly observed in
anxiety and PTSD18 and has also been reported in patients
with vulvar pain.16 Evidence suggests that stress can also
trigger the neuroinflammatory system in the brain, and in-
flammatory mediators such as cytokines (potent modulators
of behavior and affect) that can induce depressive symptoms
are also involved in the process of pathological pain.40,48–50
Investigations into chronic musculoskeletal pain and the
co-occurrence of PTSD suggest that physiological, affective,
and behavioral components of PTSD may maintain or ex-
acerbate symptoms of pain.41 Likewise, cognitive, affective,
and behavioral components of chronic pain may maintain or
exacerbate symptoms of PTSD.15
An important limitation of this analysis is the cross-
sectional design, and hence the temporal relationship between
vulvar pain and the psychological conditions (depression and
PTSD) cannot be established. While we used validated
screening instruments with strong psychometric properties to
assess depression and PTSD, these instruments only measure
current mental health status. We also lacked information from
clinical structured interviews—the gold standard—to assess
these disorders. Furthermore, it is possible that women with
vulvar pain may be more likely to report symptoms of de-
pression and PTSD compared with women without vulvar
pain. While we cannot precisely determine the extent to which
differential reporting might bias our results, such misclassifi-
cation may lead to an overestimation of the prevalence ratio
estimates. However, the direction and magnitude of the asso-
ciations we observed are consistent with previous studies.5–7,12
Misclassification of vulvodynia status is also possible since
cases of vulvodyniawere not clinically confirmed.However, we
used a validated screening questionnaire, with high sensitivity
(81.8%) and specificity (96.6%) when compared with clinical
examination.25We cannot rule out residual confounding related
Table 2. Unadjusted and Adjusted Estimates of Prevalence Ratios for Vulvodynia Status and Mental
Health Conditions (Depression and PTSD) from the Woman to Woman Health Study
Unadjusted modelsa Adjusted modelb
Vulvodynia
Short-term or past
vulvar symptoms Vulvodynia
Short-term or past
vulvar symptoms
Mental health
condition
Prevalence
ratios
95%
Confidence
interval
Prevalence
ratios
95%
Confidence
interval
Adjusted
prevalence
ratios
95%
Confidence
interval
Adjusted
prevalence
ratios
95%
Confidence
interval
Screened positive
for depressionc
1.64*** 1.22–2.20 0.89 0.73–1.09 1.53** 1.12–2.10 0.85 0.69–1.06
PTSD screeningd:
Suggestive positive
for PTSD
1.49* 1.01–2.19 1.28* 1.04–1.57 1.54* 1.04–2.29 1.27* 1.03–1.56
Screen positive
for PTSD
2.21* 1.01–4.81 1.64* 1.09–2.46 2.37* 1.07–5.25 1.62* 1.07–2.44
aUnadjusted models were analyzed as separate models for depression and PTSD. The models compared vulvodynia with women without
vulvodynia (reference).
bAdjusted model includes depression, PTSD, and race/ethnicity, marital status, education, and sexual intercourse in the past 6 months.
The model compared vulvodynia with women without vulvodynia (reference).
cWomen who screened negative for depression are the referent.
dWomen who screened negative for PTSD are the referent.
*p £ 0.05, **p £ 0.01, ***p £ 0.001.
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to unmeasured factors such as inflammation, childhood victim-
ization, and affect-based chronic stressors thatmaybe associated
with vulvodynia status and mental health outcomes (depression
and PTSD).36,40,51
Despite these limitations, our study has important clinical
and public health implications. The prevalence of vulvodynia
was more than two-fold higher among women who screened
positive for PTSD than among other women in this population-
based study. Given the association between vulvar pain and
these mental health disorders, a holistic approach to the
treatment of women with vulvodynia may be advantageous.
Beyond established pharmacological treatments, cognitive
behavioral therapy (CBT) and the use of psychological tech-
niques such as relaxation and stress management might be
useful. An example of this approach is mindfulness-based
cognitive therapy,52 an evidence-based program on stress re-
duction for coping with stress, chronic illness, or pain that
enables the patient to increase her awareness and facilitate early
recognition of any recurring thought pattern that may be as-
sociated with depressive symptoms, anxiety, and/or pain.52–54
Support for the efficacy of cognitive behavioral therapy for
the treatment of women with vulvodynia has been investigated
in two uncontrolled55,56 and two randomized clinical tri-
als.57,58 In these studies, women with vulvodynia in the CBT
condition had a 21%–42% decrease in pain severity.57,58 CBT,
relative to supportive psychotherapy, resulted in significantly
greater improvement in pain severity during physician exam-
ination ( p= 0.014), and greater improvement in sexual func-
tion ( p= 0.034), from pretreatment to posttreatment.58
In summary, this paper documented a strong association
between PTSD and the risk of having vulvodynia and a
moderate association between depression and the risk of
having vulvodynia. A better understanding of the temporal
relationships between vulvar pain and these mental health
conditions will help to advance research in this area. Im-
proving our knowledge of how stressful life events influence
risk of vulvar pain, depression, and PTSD may be a fruitful
area for future research. Further research on the intercon-
nection between the neurobiological pathways that involve
vulvar pain, PTSD, and depression is warranted. Research on
treatment approaches that address both the pain component
as well as any associated psychological conditions may also
improve the quality of life of women with vulvodynia and
ameliorate the profound impact that PTSD, depression, and
vulvar pain have on women’s lives.
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